EP1434783A4 - Proteines de mammiferes lp et reactifs associes - Google Patents

Proteines de mammiferes lp et reactifs associes

Info

Publication number
EP1434783A4
EP1434783A4 EP02719036A EP02719036A EP1434783A4 EP 1434783 A4 EP1434783 A4 EP 1434783A4 EP 02719036 A EP02719036 A EP 02719036A EP 02719036 A EP02719036 A EP 02719036A EP 1434783 A4 EP1434783 A4 EP 1434783A4
Authority
EP
European Patent Office
Prior art keywords
mammalian proteins
related reagents
reagents
mammalian
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02719036A
Other languages
German (de)
English (en)
Other versions
EP1434783A2 (fr
Inventor
Bernard Yaovi Amegadzie
Margret Barbara Basinski
Dayue Chen
Chongxi Huang
Gerald Patrick Keleher
Douglas Raymond Perkins
Paul Robert Junior Rosteck
Scott William Rowlinson
Patanjali Raghavac Sankhavaram
Eugene Thomas Seno
Eric Wen Su
Yu Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP1434783A2 publication Critical patent/EP1434783A2/fr
Publication of EP1434783A4 publication Critical patent/EP1434783A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
EP02719036A 2001-03-16 2002-03-01 Proteines de mammiferes lp et reactifs associes Withdrawn EP1434783A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US27659601P 2001-03-16 2001-03-16
US276596P 2001-03-16
US28365401P 2001-04-13 2001-04-13
US283654P 2001-04-13
US28523801P 2001-04-20 2001-04-20
US285238P 2001-04-20
US28854801P 2001-05-03 2001-05-03
US288548P 2001-05-03
US29035101P 2001-05-11 2001-05-11
US290351P 2001-05-11
PCT/US2002/005093 WO2002074906A2 (fr) 2001-03-16 2002-03-01 Proteines de mammiferes lp et reactifs associes

Publications (2)

Publication Number Publication Date
EP1434783A2 EP1434783A2 (fr) 2004-07-07
EP1434783A4 true EP1434783A4 (fr) 2006-06-07

Family

ID=27540603

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02719036A Withdrawn EP1434783A4 (fr) 2001-03-16 2002-03-01 Proteines de mammiferes lp et reactifs associes

Country Status (3)

Country Link
EP (1) EP1434783A4 (fr)
AU (1) AU2002250143A1 (fr)
WO (1) WO2002074906A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2381790A (en) * 2001-09-26 2003-05-14 Glaxo Group Ltd LDL-receptor polypeptides
CA2574177C (fr) * 2004-07-22 2019-01-08 Eisai Co., Ltd. Lrp4/corine, marqueurs de cellules progeniteurs neuronaux dopaminergiques
JP4618736B2 (ja) * 2004-07-22 2011-01-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Lrp4/Corinドーパミン産生ニューロン前駆細胞マーカー
JP4717797B2 (ja) * 2004-07-22 2011-07-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 Lrp4/Corinドーパミン産生ニューロン前駆細胞マーカー
US8067161B2 (en) 2005-08-18 2011-11-29 Eisai R&D Management Co., Ltd. Dopaminergic neuron proliferative progenitor cell marker Nato3
WO2013015457A1 (fr) 2011-07-27 2013-01-31 Kyoto University Nouveaux marqueurs pour des cellules progénitrices de neurone dopaminergique
EP2905622A1 (fr) * 2014-02-07 2015-08-12 Institut D'Investigaciones Biomédiques August Pi i Sunyer Diagnostic d'une maladie neurologique

Citations (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016075A1 (fr) * 1994-11-18 1996-05-30 The Regents Of The University Of California Peptides antibiotiques du type cryptdines et procedes d'utilisation
US5750504A (en) * 1993-12-24 1998-05-12 Zeneca Agrochemicals Antimicrobial proteins
WO1998046743A1 (fr) * 1997-04-15 1998-10-22 The Wellcome Trust Limited As Trustee To The Wellcome Trust Nouveau recepteur de ldl
WO1999002714A1 (fr) * 1997-07-07 1999-01-21 Abbott Laboratories Reactifs et procedes utilises pour detecter les maladies du sein
WO2000055629A2 (fr) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2000061754A2 (fr) * 1999-04-09 2000-10-19 Curagen Corporation Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2000077255A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 proteines humaines secretees
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001055314A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001062927A2 (fr) * 2000-02-24 2001-08-30 Incyte Genomics Inc Molecules utilisees a des fins diagnostiques et therapeutiques
WO2001066689A2 (fr) * 2000-03-07 2001-09-13 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001066690A2 (fr) * 2000-03-06 2001-09-13 Smithkline Beecham Corporation Nouveaux composes
WO2001072961A2 (fr) * 2000-03-24 2001-10-04 Smithkline Beecham Corporation Nouveaux composes
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001079294A2 (fr) * 2000-04-19 2001-10-25 Curagen Corporation Nouvelles proteines humaines, polynucleotides les codant et procedes permettant de les utiliser
WO2001087917A1 (fr) * 2000-05-18 2001-11-22 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002000843A2 (fr) * 2000-06-23 2002-01-03 Millennium Pharmaceuticals, Inc. 56739, nouvelle proteine contenant un domaine cub et utilisations de cette proteine
WO2002004600A2 (fr) * 2000-07-12 2002-01-17 Smithkline Beecham Corporation Nouveaux composes
WO2002014368A2 (fr) * 2000-08-16 2002-02-21 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002020754A2 (fr) * 2000-09-05 2002-03-14 Incyte Genomics, Inc. Molecules utilisees a des fins diagnostiques et therapeutiques
WO2002063009A2 (fr) * 2001-02-02 2002-08-15 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
WO2002064792A2 (fr) * 2001-01-05 2002-08-22 Incyte Genomics, Inc. Molecules utiles pour detecter et traiter des maladies
WO2002066643A2 (fr) * 2000-11-13 2002-08-29 Curagen Corporation Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation
WO2002068652A2 (fr) * 2001-02-26 2002-09-06 Curagen Corporation Proteines et acides nucleiques codant ces proteines
WO2002068579A2 (fr) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits tels que des dosages d'acides nucleiques comprenant une majorite d'exons ou de transcrits humains, destines a detecter l'expression et pouvant avoir d'autres applications
WO2002070669A2 (fr) * 2001-03-06 2002-09-12 Incyte Genomics, Inc. Proteines secretees
WO2002072794A2 (fr) * 2001-03-12 2002-09-19 Incyte Genomics, Inc. Proteines de la superfamille des immunoglobulines
WO2002079449A2 (fr) * 2001-03-28 2002-10-10 Incyte Genomics, Inc. Molecules permettant de detecter et de traiter des maladies
WO2002101080A2 (fr) * 2001-05-16 2002-12-19 Pe Corporation (Ny) Proteines secretees humaines isolees, molecules d'acide nucleique codant pour ces proteines secretees humaines et utilisations de ces dernieres
WO2003000863A2 (fr) * 2001-06-22 2003-01-03 Pioneer Hi-Bred International, Inc. Polynucleotides de defensine et methodes d'utilisation
WO2003002765A2 (fr) * 2001-06-27 2003-01-09 Cancer Research Technology Limited Cancer
WO2003002610A1 (fr) * 2001-06-29 2003-01-09 Incyte Genomics, Inc. Messagers extracellulaires
EP1308459A2 (fr) * 2001-11-05 2003-05-07 Helix Research Institute Séquences d'ADN complementaires pleine longueur
WO2003054152A2 (fr) * 2001-12-10 2003-07-03 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides
WO2003058201A2 (fr) * 2001-12-31 2003-07-17 Quark Biotech, Inc. Procedes permettant d'identifier des genes marqueurs pour le cancer
WO2003064616A2 (fr) * 2002-01-31 2003-08-07 Temple University - Of The Commonwealth System Of Higher Education Composes et methodes pour induire l'arret de croissance et l'apoptose

Patent Citations (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731149A (en) * 1992-05-26 1998-03-24 The Shriner's Hospital For Crippled Children Antibiotic cryptdin peptides and methods of their use
US5750504A (en) * 1993-12-24 1998-05-12 Zeneca Agrochemicals Antimicrobial proteins
WO1996016075A1 (fr) * 1994-11-18 1996-05-30 The Regents Of The University Of California Peptides antibiotiques du type cryptdines et procedes d'utilisation
WO1998046743A1 (fr) * 1997-04-15 1998-10-22 The Wellcome Trust Limited As Trustee To The Wellcome Trust Nouveau recepteur de ldl
WO1999002714A1 (fr) * 1997-07-07 1999-01-21 Abbott Laboratories Reactifs et procedes utilises pour detecter les maladies du sein
WO2000055629A2 (fr) * 1999-03-15 2000-09-21 Eos Biotechnology, Inc. Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein
WO2000058473A2 (fr) * 1999-03-31 2000-10-05 Curagen Corporation Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2000061754A2 (fr) * 1999-04-09 2000-10-19 Curagen Corporation Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2000077255A1 (fr) * 1999-06-11 2000-12-21 Human Genome Sciences, Inc. 49 proteines humaines secretees
EP1074617A2 (fr) * 1999-07-29 2001-02-07 Helix Research Institute Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001055314A2 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001062927A2 (fr) * 2000-02-24 2001-08-30 Incyte Genomics Inc Molecules utilisees a des fins diagnostiques et therapeutiques
WO2001066690A2 (fr) * 2000-03-06 2001-09-13 Smithkline Beecham Corporation Nouveaux composes
WO2001066689A2 (fr) * 2000-03-07 2001-09-13 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001072961A2 (fr) * 2000-03-24 2001-10-04 Smithkline Beecham Corporation Nouveaux composes
WO2001075067A2 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2001079294A2 (fr) * 2000-04-19 2001-10-25 Curagen Corporation Nouvelles proteines humaines, polynucleotides les codant et procedes permettant de les utiliser
WO2001087917A1 (fr) * 2000-05-18 2001-11-22 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002000843A2 (fr) * 2000-06-23 2002-01-03 Millennium Pharmaceuticals, Inc. 56739, nouvelle proteine contenant un domaine cub et utilisations de cette proteine
WO2002004600A2 (fr) * 2000-07-12 2002-01-17 Smithkline Beecham Corporation Nouveaux composes
WO2002014368A2 (fr) * 2000-08-16 2002-02-21 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002020754A2 (fr) * 2000-09-05 2002-03-14 Incyte Genomics, Inc. Molecules utilisees a des fins diagnostiques et therapeutiques
WO2002066643A2 (fr) * 2000-11-13 2002-08-29 Curagen Corporation Proteines, polynucleotides codant pour ces proteines et procedes d'utilisation
WO2002064792A2 (fr) * 2001-01-05 2002-08-22 Incyte Genomics, Inc. Molecules utiles pour detecter et traiter des maladies
WO2002068579A2 (fr) * 2001-01-10 2002-09-06 Pe Corporation (Ny) Kits tels que des dosages d'acides nucleiques comprenant une majorite d'exons ou de transcrits humains, destines a detecter l'expression et pouvant avoir d'autres applications
WO2002063009A2 (fr) * 2001-02-02 2002-08-15 Eli Lilly And Company Proteines de mammiferes lp et reactifs associes
WO2002068652A2 (fr) * 2001-02-26 2002-09-06 Curagen Corporation Proteines et acides nucleiques codant ces proteines
WO2002070669A2 (fr) * 2001-03-06 2002-09-12 Incyte Genomics, Inc. Proteines secretees
WO2002072794A2 (fr) * 2001-03-12 2002-09-19 Incyte Genomics, Inc. Proteines de la superfamille des immunoglobulines
WO2002079449A2 (fr) * 2001-03-28 2002-10-10 Incyte Genomics, Inc. Molecules permettant de detecter et de traiter des maladies
WO2002101080A2 (fr) * 2001-05-16 2002-12-19 Pe Corporation (Ny) Proteines secretees humaines isolees, molecules d'acide nucleique codant pour ces proteines secretees humaines et utilisations de ces dernieres
WO2003000863A2 (fr) * 2001-06-22 2003-01-03 Pioneer Hi-Bred International, Inc. Polynucleotides de defensine et methodes d'utilisation
WO2003002765A2 (fr) * 2001-06-27 2003-01-09 Cancer Research Technology Limited Cancer
WO2003002610A1 (fr) * 2001-06-29 2003-01-09 Incyte Genomics, Inc. Messagers extracellulaires
EP1308459A2 (fr) * 2001-11-05 2003-05-07 Helix Research Institute Séquences d'ADN complementaires pleine longueur
WO2003054152A2 (fr) * 2001-12-10 2003-07-03 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides
WO2003058201A2 (fr) * 2001-12-31 2003-07-17 Quark Biotech, Inc. Procedes permettant d'identifier des genes marqueurs pour le cancer
WO2003064616A2 (fr) * 2002-01-31 2003-08-07 Temple University - Of The Commonwealth System Of Higher Education Composes et methodes pour induire l'arret de croissance et l'apoptose

Non-Patent Citations (52)

* Cited by examiner, † Cited by third party
Title
BLOCH C ET AL: "A NEW FAMILY OF SMALL (5 KDA) PROTEIN INHIBITORS OF INSECT ALPHA-AMYLASES FROM SEEDS OR SORGHUM (SORGHUM BICOLOR (L) MOENCH) HAVE SEQUENCE HOMOLOGIES WITH WHEAT GAMMA-PUROTHIONINS", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 279, no. 1, February 1991 (1991-02-01), pages 101 - 104, XP002041563, ISSN: 0014-5793 *
DATABASE EMBL [online] 11 February 2001 (2001-02-11), "human full-length cDNA 5-PRIME end of clone CS0DK007YE05 of HELA CELLS COT 25-NORMALIZED of Homo sapiens (human)", XP002374367, retrieved from EBI accession no. EM_PRO:CNSLT0W8E Database accession no. AL555324 *
DATABASE EMBL [online] 12 February 2001 (2001-02-12), "human full-length cDNA 3-PRIME end of clone CS0DF038YL21 of FETAL BRAIN of Homo sapiens (human)", XP002305996, retrieved from EBI accession no. EM_PRO:AL566375 Database accession no. AL566375 *
DATABASE EMBL [online] 12 February 2001 (2001-02-12), "human full-length cDNA 3-PRIME end of clone CS0DF038YL21 of FETAL BRAIN of Homo sapiens (human)", XP002374364, retrieved from EBI accession no. EM_PRO:CNSLT14RD Database accession no. AL566375 *
DATABASE EMBL [online] 12 February 2001 (2001-02-12), "human full-length cDNA 5-PRIME end of clone CS0DB003YO14 of NEUROBLASTOMA COT 10-NORMALIZED of Homo sapiens (human)", XP002374316, retrieved from EBI accession no. EM_PRO:AL583491 Database accession no. AL583491 *
DATABASE EMBL [online] 14 December 1999 (1999-12-14), "Homo sapiens BAC clone RP11-561N12 from 7, complete sequence.", XP002374313, retrieved from EBI accession no. EM_PRO:AC016769 Database accession no. AC016769 *
DATABASE EMBL [online] 14 December 1999 (1999-12-14), "Homo sapiens BAC clone RP11-561N12 from 7, complete sequence.", XP002374314, retrieved from EBI accession no. EM_PRO:AC016769 Database accession no. AC016769 *
DATABASE EMBL [online] 16 November 2001 (2001-11-16), "MEST347-G04.T3 ISUM5-RN Zea mays cDNA clone MEST347-G04 3', mRNA sequence.", XP002374329, retrieved from EBI accession no. EM_PRO:BM074930 Database accession no. BM074930 *
DATABASE EMBL [online] 17 December 2003 (2003-12-17), "Sequence 17027 from Patent EP1074617.", XP002305995, retrieved from EBI accession no. EM_PAT:AX882122 Database accession no. AX882122 *
DATABASE EMBL [online] 18 November 1999 (1999-11-18), "687021A03.x1 687 - Early embryo from Delaware Zea mays cDNA, mRNA sequence.", XP002374330, retrieved from EBI accession no. EM_PRO:AW181161 Database accession no. AW181161 *
DATABASE EMBL [online] 2 October 2001 (2001-10-02), "Homo sapiens DiGeorge syndrome-related protein FKSG3 mRNA, complete cds.", XP002374306, retrieved from EBI accession no. EM_PRO:AF305069 Database accession no. AF305069 *
DATABASE EMBL [online] 2 October 2001 (2001-10-02), "Homo sapiens DiGeorge syndrome-related protein FKSG5 mRNA, complete cds.", XP002374366, retrieved from EBI accession no. EM_PRO:AF305622 Database accession no. AF305622 *
DATABASE EMBL [online] 20 January 2000 (2000-01-20), "Homo sapiens chromosome 15 clone RP11-300N24 map 15, LOW-PASS SEQUENCE SAMPLING.", XP002374317, retrieved from EBI accession no. EM_PRO:AC021676 Database accession no. AC021676 *
DATABASE EMBL [online] 24 August 1998 (1998-08-24), "Homo sapiens mRNA for MEGF7, partial cds.", XP002374308, retrieved from EBI accession no. EM_PRO:AB011540 Database accession no. AB011540 *
DATABASE EMBL [online] 24 August 2000 (2000-08-24), "Gallus gallus CEPU-Se alpha 2 isoform (CEPU-Se) mRNA, complete cds.", XP002374315, retrieved from EBI accession no. EM_PRO:AF292935 Database accession no. AF292935 *
DATABASE EMBL [online] 29 April 1999 (1999-04-29), "rx00304s Rat mixed-tissue library Rattus norvegicus cDNA clone rx00304 3', mRNA sequence.", XP002374318, retrieved from EBI accession no. EM_PRO:AI639089 Database accession no. AI639089 *
DATABASE EMBL [online] 29 November 2000 (2000-11-29), "Mus musculus 13 days embryo cDNA, RIKEN full-length enriched library, clone:3930402I15, 5' end partial sequence.", XP002374322, retrieved from EBI accession no. EM_PRO:BB569837 Database accession no. BB569837 *
DATABASE EMBL [online] 30 April 1998 (1998-04-30), "Homo sapiens unknown mRNA.", XP002374307, retrieved from EBI accession no. EM_PRO:AF060862 Database accession no. AF060862 *
DATABASE EMBL [online] 30 July 2000 (2000-07-30), "HVSMEh0093P24f Hordeum vulgare 5-45 DAP spike EST library HVcDNA0009 (5 to 45 DAP) Hordeum vulgare cDNA clone HVSMEh0093P24f, mRNA sequence.", XP002374362, retrieved from EBI accession no. EM_PRO:BE454491 Database accession no. BE454491 *
DATABASE EMBL [online] 30 March 2001 (2001-03-30), "Homo sapiens yippee-like 3 (Drosophila), mRNA (cDNA clone MGC:10500 IMAGE:3639517), complete cds.", XP002374365, retrieved from EBI accession no. EM_PRO:BC005009 Database accession no. BC005009 *
DATABASE EMBL [online] 7 January 2000 (2000-01-07), "Rattus norvegicus mRNA for MEGF7, partial cds.", XP002374309, retrieved from EBI accession no. EM_PRO:AB011533 Database accession no. AB011533 *
DATABASE Geneseq [online] 15 January 2004 (2004-01-15), "Mouse tumour suppressor mRNA SEQ ID NO:50.", XP002374319, retrieved from EBI accession no. GSN:ADD29597 Database accession no. ADD29597 *
DATABASE Geneseq [online] 22 April 2004 (2004-04-22), "Protein of the invention SEQ ID NO:710.", XP002305994, retrieved from EBI accession no. GSP:ADJ33733 Database accession no. ADJ33733 *
DATABASE Geneseq [online] 23 March 2001 (2001-03-23), "Gene 30 human secreted protein homologous amino acid sequence #157.", XP002306004, retrieved from EBI accession no. GSP:AAB64519 Database accession no. AAB64519 *
DATABASE Geneseq [online] 25 March 2004 (2004-03-25), "NOV25 coding sequence, SEQ ID 59.", XP002374311, retrieved from EBI accession no. GSN:ADH48775 Database accession no. ADH48775 *
DATABASE Geneseq [online] 25 March 2004 (2004-03-25), "NOV25 protein sequence, SEQ ID 60.", XP002374310, retrieved from EBI accession no. GSP:ADH48776 Database accession no. ADH48776 *
DATABASE Geneseq [online] 29 January 2004 (2004-01-29), "Novel protein (useful for identifying genetic disorders) #7.", XP002374326, retrieved from EBI accession no. GSP:ADE07852 Database accession no. ADE07852 *
DATABASE Geneseq [online] 30 July 2002 (2002-07-30), "Human dithp polynucleotide #256.", XP002374320, retrieved from EBI accession no. GSN:ABK71790 Database accession no. ABK71790 *
DATABASE Geneseq [online] 4 December 2001 (2001-12-04), "Human diagnostic and therapeutic polynucleotide (DITHP) #202.", XP002374328, retrieved from EBI accession no. GSN:AAS31187 Database accession no. AAS31187 *
DATABASE Geneseq [online] 6 November 2001 (2001-11-06), "Human digestive system antigen SEQ ID NO: 1647.", XP002374363, retrieved from EBI accession no. GSP:AAM92298 Database accession no. AAM92298 *
DATABASE Geneseq [online] 8 February 2001 (2001-02-08), "Human ORFX ORF2934 polynucleotide sequence SEQ ID NO:5867.", XP002374324, retrieved from EBI accession no. GSN:AAC77379 Database accession no. AAC77379 *
DATABASE Geneseq [online] 8 February 2001 (2001-02-08), "Human ORFX ORF2934 polypeptide sequence SEQ ID NO:5868.", XP002374323, retrieved from EBI accession no. GSP:AAB43170 Database accession no. AAB43170 *
DATABASE UniProt [online] 1 June 1998 (1998-06-01), "Neural secreted glycoprotein (CEPU-Se alpha 2 isoform).", XP002374368, retrieved from EBI accession no. UNIPROT:O57596 Database accession no. O57596 *
DATABASE UniProt [online] 1 May 2000 (2000-05-01), "LDL receptor member LR3.", XP002374312, retrieved from EBI accession no. UNIPROT:Q9UES7 Database accession no. Q9UES7 *
DATABASE UniProt [online] 1 November 1996 (1996-11-01), "Protease inhibitor.", XP002374321, retrieved from EBI accession no. UNIPROT:Q39807 Database accession no. Q39807 *
DATABASE UniProt [online] 1 October 2000 (2000-10-01), "CEGP1 protein.", XP002374325, retrieved from EBI accession no. UNIPROT:Q9NQ36 Database accession no. Q9NQ36 *
DATABASE UniProt [online] 1 October 2000 (2000-10-01), "Cegp1 protein.", XP002374327, retrieved from EBI accession no. UNIPROT:Q9JJS0 Database accession no. Q9JJS0 *
DONG Y ET AL: "MOLECULAR CLONING AND CHARACTERIZATION OF LR3, A NOVEL LDL RECEPTOR FAMILY PROTEIN WITH MITOGENIC ACTIVITY", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 251, no. 3, 29 October 1998 (1998-10-29), pages 784 - 790, XP001076809, ISSN: 0006-291X *
GRIMMOND S ET AL: "Cloning, Mapping, and Expression Analysis of a Gene Encoding a Novel Mammalian EGF-Related Protein (SCUBE1)", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 70, no. 1, 15 November 2000 (2000-11-15), pages 74 - 81, XP004437770, ISSN: 0888-7543 *
HUTTNER K M ET AL: "STRUCTURE AND DIVERSITY OF THE MURINE CRYPTDIN GENE FAMILY", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 19, 1994, pages 448 - 453, XP002054342, ISSN: 0888-7543 *
J. I. KOURIE AND A. A. SHORTHOUSE: "Properties of cytotoxic peptide-formed ion channels", AM J PHYSIOL CELL PHYSIOL, vol. 278, 2000, pages C1063 - C1087, XP002374273 *
KRIEGER M ET AL: "STRUCTURES AND FUNCTIONS OF MULTILIGAND LIPOPROTEIN RECEPTORS: MACROPHAGE SCAVENGER RECEPTORS AND LDL RECEPTOR-RELATED PROTEIN (LRP)", ANNUAL REVIEW OF BIOCHEMISTRY, PALTO ALTO, CA, US, vol. 63, 1994, pages 601 - 637, XP002937333, ISSN: 0066-4154 *
LIPPMAN D A ET AL: "OPIOID-BINDING CELL ADHESION MOLECULE (OBCAM)-RELATED CLONES FROM ARAT BRAIN CDNA LIBRARY", GENE, ELSEVIER, AMSTERDAM, NL, vol. 117, no. 2, 1992, pages 249 - 254, XP000602047, ISSN: 0378-1119 *
LODGE A P ET AL: "Co-localisation, heterophilic interactions and regulated expression of IgLON family proteins in the chick nervous system", MOLECULAR BRAIN RESEARCH, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 82, 2000, pages 84 - 94, XP002977169, ISSN: 0169-328X *
MENDEZ E ET AL: "PRIMARY STRUCTURE OF OMEGA-HORDOTHIONIN, A MEMBER OF A NOVEL FAMILY OF THIONINS FROM BARLEY ENDOSPERM, AND ITS INHIBITION OF PROTEIN SYNTHESIS IN EUKARYOTIC AND PROLARYOTIC CELL-FREE SYSTEMS", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 239, no. 1, 1996, pages 67 - 73, XP001182417, ISSN: 0014-2956 *
MORIYAMA TATSUYA ET AL: "Purification and characterization of diacylglycerol lipase from human platelets", JOURNAL OF BIOCHEMISTRY (TOKYO), vol. 125, no. 6, June 1999 (1999-06-01), pages 1077 - 1085, XP002305993, ISSN: 0021-924X *
NEELS J G ET AL: "Interaction Between Factor VIII and LDL Receptor-related Protein. MODULATION OF COAGULATION?", TRENDS IN CARDIOVASCULAR MEDICINE, ELSEVIER SCIENCE, NEW YORK, NY, US, vol. 10, no. 1, 2000, pages 8 - 14, XP002264412, ISSN: 1050-1738 *
OUELLETTE A J ET AL: "A NOVEL MOUSE GENE FAMILY CODING FOR CATIONIC, CYSTEINE-RICH PEPTIDES", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 265, no. 17, 15 June 1990 (1990-06-15), pages 9831 - 9837,18702, XP000615234, ISSN: 0021-9258 *
SCHOFIELD P R ET AL: "MOLECULAR CHARACTERIZATION OF A NEW IMMUNOGLOBULIN SUPERFAMILY PROTEIN WITH POTENTIAL ROLES IN OPIOID BINDING AND CELL CONTACT", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 8, no. 2, 1 February 1989 (1989-02-01), pages 489 - 495, XP000602249, ISSN: 0261-4189 *
SHARK K B ET AL: "Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a human opioid-binding cell adhesion molecule (OBCAM)", GENE, ELSEVIER, AMSTERDAM, NL, vol. 155, no. 2, 3 April 1995 (1995-04-03), pages 213 - 217, XP004042416, ISSN: 0378-1119 *
SOUZA CASTRO DE M ET AL: "COMPLETE AMINO ACID SEQUENCES OF TWO GAMMA-THIONINS FROM MAIZE (ZEAMAYS L.) SEEDS", PROTEIN AND PEPTIDE LETTERS, BENTHAM SCIENCE PUBLISHERS, SCHIPHOL, NL, vol. 3, no. 4, 1 August 1996 (1996-08-01), pages 267 - 274, XP000623654, ISSN: 0929-8665 *
STRUYK A F ET AL: "CLONING OF NEUROTRIMIN DEFINES A NEW SUBFAMILY OF DIFFERENTIALLY EXPRESSED NEURAL CELL ADHESION MOLECULES", JOURNAL OF NEUROSCIENCE, NEW YORK, NY, US, vol. 15, no. 3, March 1995 (1995-03-01), pages 2141 - 2156, XP000953464, ISSN: 0270-6474 *

Also Published As

Publication number Publication date
AU2002250143A1 (en) 2002-10-03
WO2002074906A3 (fr) 2004-04-22
EP1434783A2 (fr) 2004-07-07
WO2002074906A2 (fr) 2002-09-26

Similar Documents

Publication Publication Date Title
EP1487865A4 (fr) Utilisations d'une cytokine mammifere et reactifs associes
GB0130557D0 (en) Proteins
GB0130720D0 (en) Proteins
AU2002326367A1 (en) Lp mammalian proteins; related reagents
EP1434783A4 (fr) Proteines de mammiferes lp et reactifs associes
EP1464701A4 (fr) Proteines fluorescentes
EP1437410A4 (fr) Nouvelles proteines contenant de la selenocysteine
AU2002358273A1 (en) Nucleic acid-associated proteins
AU2002249928A1 (en) Lp mammalian proteins; related reagents
AU2002359333A1 (en) Nucleic acid-associated proteins
GB0105402D0 (en) Novel proteins
AU2002355292A1 (en) Nucleic acid-associated proteins
AU2002326808A1 (en) Mammalian genes; related reagents
AU2002345422A1 (en) Nucleic acid-associated proteins
AU2002344252A1 (en) Mammalian diabetes-mediating proteins
AU2002326372A1 (en) Nucleic acid-associated proteins
GB0117193D0 (en) Protein modification reagents
IL160811A0 (en) Fluorescent proteins
AU2002256993A1 (en) Nucleic acid-associated proteins
AU2002256065A1 (en) Nucleic acid-associated proteins
AU2002364926A1 (en) Nucleic acid-associated proteins
AU2002326332A1 (en) Nucleic acid-associated proteins
EP1373306A4 (fr) Proteines associees au cytoskeleton
GB0100750D0 (en) Novel proteins
GB0105401D0 (en) Novel proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

17P Request for examination filed

Effective date: 20041022

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 12N 15/12 A

A4 Supplementary search report drawn up and despatched

Effective date: 20060427

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060729